Researchers develop vaccine to fight opioid misuse, addiction

Immunizations for the flu, smallpox and polio are essential in protecting against dangerous diseases. Now, widespread opioid addiction has pushed researchers to develop a vaccine against the effects of overdose and misuse.

According to results presented at the National Meeting & Exposition of the American Chemical Society (ACS), researchers are developing a vaccine against the growing threat of opioid addiction. The vaccine was developed to prevent opioid receptors in the body from attaching to antibodies, a method that involved the linking together of the opioid molecules which are normally too small to block.

"There is an urgent need to discover effective medications to treat substance use disorders. Increasingly, drug users are turning to opioids and powerful synthetic versions of these drugs that can sometimes be as much as 100 times more potent than heroin," said Kim D. Janda, PhD, head of the vaccine research team.

Read the full story below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”